Mosaic ImmunoEngineering (CPMV) Other Accumulated Expenses (2020 - 2026)
Mosaic ImmunoEngineering (CPMV) posted quarterly Other Accumulated Expenses of $40900.0 for Q1 2026, little changed year-over-year from $40900.0 in Q1 2025, and little changed quarter-over-quarter from $40900.0 in Q4 2025.
Mosaic ImmunoEngineering (CPMV) Other Accumulated Expenses (2020 - 2026) Analysis & Trends
Mosaic ImmunoEngineering's Other Accumulated Expenses history runs 7 years deep, the most recent figure standing at $40900.0 for Q1 2026.
- In Q1 2026, Other Accumulated Expenses changed 0.0% year-over-year to $40900.0; the TTM figure through Mar 2026 stood at $40900.0 (changed 0.0% YoY), while the FY2025 annual figure was $40900.0, changed 0.0% from the prior year.
- Other Accumulated Expenses for Q1 2026 stood at $40900.0, roughly flat from $40900.0 in the prior quarter.
- The five-year high for Other Accumulated Expenses was $83512.0 in Q1 2022, with the low at $1725.0 in Q2 2022.
- The 5-year median for Other Accumulated Expenses is $40900.0 (2024), against an average of $35098.4.
- The sharpest annual moves came in 2022 and 2024: Other Accumulated Expenses sank 96.1% in 2022, then surged 1128.26% in 2024.
- Mosaic ImmunoEngineering's Other Accumulated Expenses stood at $17700.0 in 2022, then surged by 91.53% to $33900.0 in 2023, then gained by 20.65% to $40900.0 in 2024, then changed by 0.0% to $40900.0 in 2025, then changed by 0.0% to $40900.0 in 2026.
- Business Quant data shows CPMV's Other Accumulated Expenses at $40900.0 in Q1 2026, $40900.0 in Q4 2025, and $40900.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Mosaic ImmunoEngineering | 3.68 Mn | 3.68 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 40,900.00 |
| Dec 31, 2025 | 40,900.00 |
| Sep 30, 2025 | 40,900.00 |
| Jun 30, 2025 | 40,900.00 |
| Mar 31, 2025 | 40,900.00 |
| Dec 31, 2024 | 40,900.00 |
| Sep 30, 2024 | 40,900.00 |
| Jun 30, 2024 | 33,900.00 |
| Mar 31, 2024 | 33,900.00 |
| Dec 31, 2023 | 33,900.00 |
| Sep 30, 2023 | 51,837.00 |
| Jun 30, 2023 | 2,760.00 |
| Mar 31, 2023 | 14,058.00 |
| Dec 31, 2022 | 17,700.00 |
| Sep 30, 2022 | 37,080.00 |
| Jun 30, 2022 | 1,725.00 |
| Mar 31, 2022 | 83,512.00 |
| Dec 31, 2021 | 31,143.00 |
| Sep 30, 2021 | 51,234.00 |
| Jun 30, 2021 | 44,195.00 |